Page last updated: 2024-09-04

irofulven and Carcinoma, Small Cell

irofulven has been researched along with Carcinoma, Small Cell in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kashimoto, S; MacDonald, JR; Nakano, K; Sato, Y1

Other Studies

1 other study(ies) available for irofulven and Carcinoma, Small Cell

ArticleYear
In vivo antitumour efficacy of MGI-114 (6-hydroxymethylacylfulvene, HMAF) in various human tumour xenograft models including several lung and gastric tumours.
    European journal of cancer (Oxford, England : 1990), 2001, Volume: 37, Issue:11

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Alkylating; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Colonic Neoplasms; Humans; Lung Neoplasms; Melanoma; Mice; Mice, Nude; Sesquiterpenes; Stomach Neoplasms; Xenograft Model Antitumor Assays

2001